Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

OTHER 1

Study Type

Interventional 344Observational 1Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Melanoma 1Lymphoma, Mantle-Cell 1Leukemia 1KRAS G12V Mutant Advanced Epithelial Cancers 1Immunoproliferative Disorders 1Immune System Diseases 1

Interventions

fludarabine phosphate 2tisagenlecleucel 1revumenib 1ponatinib 1midostaurin 1immunotoxin HA22 1glucarpidase 1fludarabine 1Whole-Body Irradiation 1Tacrolimus 1Mycophenolic Acid 1HA 22 1Cytarabine 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Carboxypeptidases 1Busulfan 1Bone Marrow Transplantation 1AP 1903 reagent 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × Leukemia × Cyclophosphamide × Clear all
NCT03594162 2021-12-03

Compassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch

UNC Lineberger Comprehensive Cancer Center

No longer available
LymphoidOther hematologic neoplasm

Immune System Diseases, Immunoproliferative Disorders, Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡